The Enterprise Value as of December 2025 (TTM) for BeOne Medicines Ltd. Class A (688235.SS) is 38.97B

According to BeOne Medicines Ltd. Class A’s latest financial reports and current stock price. The company's current Enterprise Value is 38.97B. This represents a change of 2.59% compared to the average of 1.45B of the last 4 quarters.

BeOne Medicines Ltd. Class A (688235.SS) Historical Enterprise Value (quarterly & annually)

How has 688235.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of BeOne Medicines Ltd. Class A over the last ten years is 260.93M. The current 38.97B Enterprise Value has changed 1.49% with respect to the historical average. Over the past ten years (40 quarters), 688235.SS's Enterprise Value was at its highest in in the March 2025 quarter at 2.14B. The Enterprise Value was at its lowest in in the June 2022 quarter at -2374613894.94.

BeOne Medicines Ltd. Class A (688235.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BeOne Medicines Ltd. Class A Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BeOne Medicines Ltd. Class A (688235.SS) Average Enterprise Value

How has 688235.SS Enterprise Value performed in the past?

The current Enterprise Value of BeOne Medicines Ltd. Class A (688235.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BeOne Medicines Ltd. Class A (688235.SS) Enterprise Value vs. Peers

How is 688235.SS’s Enterprise Value compared to its peers?

BeOne Medicines Ltd. Class A’s Enterprise Value is less than WuXi AppTec Co., Ltd. (214.51B), less than Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (223.25B), less than Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (56.79B), less than Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (60.58B), greater than Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (36.85B), less than RemeGen Co Ltd (45.85B), greater than Shanghai Junshi Biosciences Co., Ltd. (35.89B), greater than Nanjing Vazyme Biotech Co., Ltd. (8.09B), greater than Suzhou Zelgen Biopharmaceuticals Co., Ltd. (25.90B), greater than Sinocelltech Group Limited (23.44B),

Build a custom stock screener for BeOne Medicines Ltd. Class A (688235.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BeOne Medicines Ltd. Class A using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BeOne Medicines Ltd. Class A (688235.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BeOne Medicines Ltd. Class A or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.